Last updated at 15 Nov 2025 01:56 AM
Director
DIN: 03642447
Jayeshkumar Vallabhabhai Kakadiya is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at VOLENS PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03642447.Jayeshkumar Vallabhabhai Kakadiya is currently involved in 2 different roles. Their most recent position is with AKSHAR POWER TOOL PRIVATE LIMITED as a Director. The first company Jayeshkumar Vallabhabhai Kakadiya was appointed to as a director was VOLENS PHARMACEUTICALS PRIVATE LIMITED. Jayeshkumar Vallabhabhai Kakadiya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jayeshkumar Vallabhabhai Kakadiya is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at VOLENS PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03642447.Jayeshkumar Vallabhabhai Kakadiya is currently involved in 2 different roles. Their most recent position is with AKSHAR POWER TOOL PRIVATE LIMITED as a Director. The first company Jayeshkumar Vallabhabhai Kakadiya was appointed to as a director was VOLENS PHARMACEUTICALS PRIVATE LIMITED. Jayeshkumar Vallabhabhai Kakadiya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
2y 10m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| VOLENS PHARMACEUTICALS PRIVATE LIMITED | Director | 21-Nov-2011 |
| AKSHAR POWER TOOL PRIVATE LIMITED | Director | 14-Nov-2025 |